| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $46.0M | $41.0M | $77.4M |
| YoY Revenue Growth % | +12.1% | -47.1% | — |
| Gross Profit | -$7.4M | -$2.1M | — |
| Gross Margin % | -16.1% | -5.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$54.9M | -$78.8M | -$133.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$71.4M | -$69.7M | -$135.1M |
| EBITDA (Normalized) | -$52.7M | -$78.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$27.3M | -$32.7M | -$105.6M |
| Capital Expenditures (CapEx) | $2.7M | $9.0K | — |
| Free Cash Flow (FCF) | -$30.0M | -$32.7M | -$105.6M |
| FCF Margin % | -65.3% | -79.7% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $39.0M | $1.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $38.2M | $39.7M | — |